Literature DB >> 12923038

Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure.

S G Williams, D J Wright, P Marshall, A Reese, B-H Tzeng, A J S Coats, L-B Tan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12923038      PMCID： PMC1767846          DOI： 10.1136/heart.89.9.1085

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients.

Authors:  G A Cooke; S G Williams; P Marshall; J K Al-Timman; J Shelbourne; D J Wright; L-B Tan
Journal:  Eur Heart J       Date:  2002-09       Impact factor: 29.983

Review 2.  The cardiovascular actions of morphine and the endogenous opioid peptides.

Authors:  M W Johnson; W E Mitch; C S Wilcox
Journal:  Prog Cardiovasc Dis       Date:  1985 May-Jun       Impact factor: 8.194

3.  Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure.

Authors:  T P Chua; D Harrington; P Ponikowski; K Webb-Peploe; P A Poole-Wilson; A J Coats
Journal:  J Am Coll Cardiol       Date:  1997-01       Impact factor: 24.094

4.  Ventilation and gas exchange during exercise in severe chronic heart failure.

Authors:  S A Rubin; H V Brown
Journal:  Am Rev Respir Dis       Date:  1984-02

5.  Detrimental haemodynamic effects of cyclizine in heart failure.

Authors:  L B Tan; S Bryant; R G Murray
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321
  5 in total
  8 in total

Review 1.  Palliative care for end-stage heart failure.

Authors:  Sarah J Goodlin
Journal:  Curr Heart Fail Rep       Date:  2005-09

2.  Dyspnoea associated with anxiety--symptomatic therapy with opioids in combination with lorazepam and its effect on ventilation in palliative care patients.

Authors:  Katri Elina Clemens; Eberhard Klaschik
Journal:  Support Care Cancer       Date:  2010-12-14       Impact factor: 3.603

3.  Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence?

Authors:  Markus Hochgerner; Friedrich M Fruhwald; Imke Strohscheer
Journal:  Wien Med Wochenschr       Date:  2009-12

Review 4.  End-of-life care in heart failure.

Authors:  Sarah J Goodlin
Journal:  Curr Cardiol Rep       Date:  2009-05       Impact factor: 2.931

Review 5.  The symptomatic relief of dyspnea.

Authors:  Giovanni Elia; Jay Thomas
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

Review 6.  End-of-Life Care for End-stage Heart Failure Patients.

Authors:  Ju-Hee Lee; Kyung-Kuk Hwang
Journal:  Korean Circ J       Date:  2022-09       Impact factor: 3.101

7.  Low dose of morphine to relieve dyspnea in acute respiratory failure (OpiDys): protocol for a double-blind randomized controlled study.

Authors:  Alexandre Demoule; Robin Deleris; Côme Bureau; Said Lebbah; Maxens Decavèle; Martin Dres; Thomas Similowski; Agnes Dechartres
Journal:  Trials       Date:  2022-09-30       Impact factor: 2.728

8.  Hospital without dyspnea: rationale and design of a multidisciplinary intervention.

Authors:  Lourdes Vicent; Juan Manuel Nuñez Olarte; Luis Puente-Maestu; Esther Artajona; Francisco Fernández-Avilés; Manuel Martínez-Sellés
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.